{"database": "openregs", "table": "federal_register", "rows": [["2012-30516", "Impact of Approved Drug Labeling on Chronic Opioid Therapy; Public Hearing; Request for Comments", "Notice", "The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain.", "2012-12-19", 2012, 12, "https://www.federalregister.gov/documents/2012/12/19/2012-30516/impact-of-approved-drug-labeling-on-chronic-opioid-therapy-public-hearing-request-for-comments", "https://www.govinfo.gov/content/pkg/FR-2012-12-19/pdf/2012-30516.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain.", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2012-30516"], "units": {}, "query_ms": 0.34123496152460575, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}